Published in J Natl Cancer Inst on May 01, 1991
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut (2001) 4.97
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
Characterization of Helicobacter pylori urease mutants. Infect Immun (1992) 1.93
Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol (2012) 1.53
Isolation and characterization of a family of porin proteins from Helicobacter pylori. Infect Immun (1995) 1.52
Prevalence and varieties of Helicobacter species in dogs from random sources and pet dogs: animal and public health implications. J Clin Microbiol (1996) 1.50
Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. J Clin Pathol (1994) 1.47
Adaptive mutation and cocolonization during Helicobacter pylori infection of gnotobiotic piglets. Infect Immun (1995) 1.43
Growth phase-dependent regulation of target gene promoters for binding of the essential orphan response regulator HP1043 of Helicobacter pylori. J Bacteriol (2002) 1.29
Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer (2006) 1.26
Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989. Br J Cancer (2001) 1.25
The glycerolipid receptor for Helicobacter pylori (and exoenzyme S) is phosphatidylethanolamine. Infect Immun (1992) 1.22
High prevalence of Helicobacter pylori in saliva demonstrated by a novel PCR assay. J Clin Pathol (1995) 1.15
Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori. Infect Immun (1993) 1.14
Helicobacter pylori and gastric cancer: correlation with gastritis, intestinal metaplasia, and tumour histology. Gut (1992) 1.13
Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J Biol Med (1994) 1.07
Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis. Gut (1998) 1.06
A highly specific and sensitive DNA probe derived from chromosomal DNA of Helicobacter pylori is useful for typing H. pylori isolates. J Clin Microbiol (1993) 1.06
Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev (2015) 1.05
Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice. Infect Immun (2003) 1.01
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol (2002) 0.99
Helicobacter pylori and early gastric cancer. Gut (1994) 0.96
Metallo-GTPase HypB from Helicobacter pylori and its interaction with nickel chaperone protein HypA. J Biol Chem (2011) 0.95
Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent. Infect Immun (2005) 0.95
Impact of chronologic age in the elderly with gastric cancer. J Korean Surg Soc (2012) 0.94
A histidine-rich and cysteine-rich metal-binding domain at the C terminus of heat shock protein A from Helicobacter pylori: implication for nickel homeostasis and bismuth susceptibility. J Biol Chem (2008) 0.93
Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Jpn J Clin Oncol (2008) 0.92
Gastric cancer and Helicobacter pylori infection. J Clin Pathol (1993) 0.92
Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol (2014) 0.92
Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterol Hepatol Bed Bench (2015) 0.91
Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma: significance of anti-cagA antibodies. Clin Diagn Lab Immunol (2000) 0.88
Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation. Gut (1995) 0.88
Activation of IkappaB kinase and NF-kappaB is essential for Helicobacter pylori-induced chronic gastritis in Mongolian gerbils. Infect Immun (2007) 0.87
Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets. Antimicrob Agents Chemother (1998) 0.87
Factors that mediate colonization of the human stomach by Helicobacter pylori. World J Gastroenterol (2014) 0.86
Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Dig Dis Sci (2003) 0.85
Helicobacter pylori regulates iNOS promoter by histone modifications in human gastric epithelial cells. Med Microbiol Immunol (2012) 0.85
Gastric cancer at a university teaching hospital in northwestern Tanzania: a retrospective review of 232 cases. World J Surg Oncol (2012) 0.85
Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer. Fam Cancer (2015) 0.84
Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea. Gut Liver (2010) 0.83
Polymorphisms of the acid sensing histidine kinase gene arsS in Helicobacter pylori populations from anatomically distinct gastric sites. Microb Pathog (2012) 0.82
Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia. J Clin Pathol (1996) 0.80
Long-term administration of the fungus toxin, sterigmatocystin, induces intestinal metaplasia and increases the proliferative activity of PCNA, p53, and MDM2 in the gastric mucosa of aged Mongolian gerbils. Environ Health Prev Med (2011) 0.80
Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer. BMC Genomics (2009) 0.80
Long-term infection of Mongolian gerbils with Helicobacter pylori: microbiological, histopathological, and serological analyses. Clin Diagn Lab Immunol (2005) 0.80
Clinical significance of RacGAP1 expression at the invasive front of gastric cancer. Gastric Cancer (2014) 0.80
The association between cagA+ H. pylori infection and distal gastric cancer: a proposed model. Dig Dis Sci (2004) 0.79
Somatostatin methylation as a biomarker for gastric cancer: ready for "prime time" or for further validation? Dig Dis Sci (2011) 0.79
Phenotypic Differences of Gastric Cancer according to the Helicobacter pylori Infection in Korean Patients. J Gastric Cancer (2010) 0.79
Helicobacter species are associated with possible increase in risk of biliary lithiasis and benign biliary diseases. World J Surg Oncol (2007) 0.78
Intracellular Helicobacter pylori and gastric carcinogenesis: an "old" frontier worth revisiting. Gastroenterology (2007) 0.77
Additive interactions between PRKAA1 polymorphisms and Helicobacter pylori CagA infection associated with gastric cancer risk in Koreans. Cancer Med (2016) 0.77
Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe-gastric epithelial cells cross-talk. Med Microbiol Immunol (2013) 0.77
Epidemiology of gastric cancer in the gangetic areas of west bengal. ISRN Gastroenterol (2013) 0.76
Importance of the C-terminal histidine residues of Helicobacter pylori GroES for Toll-like receptor 4 binding and interleukin-8 cytokine production. Sci Rep (2016) 0.76
Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation. Sci Rep (2016) 0.76
The British Society of Gastroenterology Diamond Jubilee. March 1997. Gut (1997) 0.75
Loss of HGF activator inhibits foveolar hyperplasia induced by oxyntic atrophy without altering gastrin levels. Am J Physiol Gastrointest Liver Physiol (2012) 0.75
Factors associated with gastro-duodenal disease in patients undergoing upper GI endoscopy at the Korle-Bu Teaching Hospital, Accra, Ghana. Afr Health Sci (2016) 0.75
Gastric autoantigenic proteins in Helicobacter pylori infection. Yonsei Med J (2013) 0.75
Association between Helicobacter pylori status and metachronous gastric cancer after endoscopic resection. World J Gastroenterol (2016) 0.75
Historical Perspective on Familial Gastric Cancer. Cell Mol Gastroenterol Hepatol (2017) 0.75
Endoscopic resection as a first therapy for gastric epithelial atypia: is it reasonable? Dig Dis Sci (2014) 0.75
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89
Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med (1995) 8.52
Kaposi's sarcoma. N Engl J Med (2000) 6.81
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57
Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int (2007) 6.35
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05
Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol (1998) 4.62
Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg (2001) 4.59
Effect of economic reforms on child growth in urban and rural areas of China. N Engl J Med (1996) 4.50
Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol (1997) 4.45
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13
The effect of enforcing tobacco-sales laws on adolescents' access to tobacco and smoking behavior. N Engl J Med (1997) 4.06
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70
RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet (1994) 3.64
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med (1996) 3.61
Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol (1996) 3.48
Cyclin encoded by KS herpesvirus. Nature (1996) 3.32
Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect Immun (1992) 2.80
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med (1997) 2.79
Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis. Cancer (1979) 2.76
Delayed posthypoxic demyelination. Association with arylsulfatase A deficiency and lactic acidosis on proton MR spectroscopy. Neurology (1997) 2.66
Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood (1999) 2.65
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer (1995) 2.64
Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med (1997) 2.64
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene (1997) 2.57
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol (2000) 2.55
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS (1996) 2.49
Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol (1999) 2.41
Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res (1981) 2.39
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
Leaving gatekeeping behind--effects of opening access to specialists for adults in a health maintenance organization. N Engl J Med (2001) 2.29
The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol (1997) 2.24
Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol (2001) 2.21
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
Surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: five-year outcomes from the Maine Lumbar Spine Study. Spine (Phila Pa 1976) (2001) 2.17
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation (2000) 2.09
The impact of choice of muscle relaxant on postoperative recovery time: a retrospective study. Anesth Analg (1997) 2.03
A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem (1997) 2.00
Long-term disability and return to work among patients who have a herniated lumbar disc: the effect of disability compensation. J Bone Joint Surg Am (2000) 1.95
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95
A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant (1991) 1.87
Congenital nephrotic syndrome: evolution of medical management and results of renal transplantation. J Pediatr (1984) 1.82
MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene (2011) 1.81
Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest (1985) 1.80
Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J Acquir Immune Defic Syndr (1993) 1.79
Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis. Ann Surg (2000) 1.76
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol (1997) 1.72
Short-acting nifedipine and risk of stroke in elderly hypertensive patients. Neurology (2011) 1.70
Nucleotide sequence of the bacteriophage P22 genes required for DNA packaging. Virology (1991) 1.67
Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.65
Antitumor activity of sorafenib in FLT3-driven leukemic cells. Leukemia (2007) 1.65
Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia (1996) 1.63
Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am J Psychiatry (2001) 1.59
Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med (1998) 1.55
Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence. J Urol (2003) 1.54
308-nm excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol (2000) 1.54
Retracted Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc Natl Acad Sci U S A (1999) 1.52
Microvillous inclusion disease. The importance of electron microscopy for diagnosis. Am J Surg Pathol (1991) 1.51
Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol (2000) 1.50
Ultrasonography by emergency physicians in patients with suspected cholecystitis. Am J Emerg Med (2001) 1.50
Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol (1999) 1.49
Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg (1989) 1.49
Duodenal gangliocytic paraganglioma. An immunohistochemical and ultrastructural study and a hypothesis concerning its origin. Am J Surg Pathol (1985) 1.48
Nasopharyngeal swab and PCR for the screening of nasopharyngeal carcinoma in the endemic area: a good supplement to the serologic screening. Head Neck (1998) 1.47
Evidence for the exchange of segments between genomes during the evolution of lambdoid bacteriophages. Mol Microbiol (1990) 1.44
Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS (1998) 1.40
Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med (1997) 1.40
Anomalous origin of one pulmonary artery from the innominate artery: a report of two cases. Pediatr Cardiol (2001) 1.40
Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc. J Clin Invest (2000) 1.40
Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases. J Biol Chem (1995) 1.39
KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood (2000) 1.39
Combined functional magnetic resonance imaging and transcranial magnetic stimulation evidence of ipsilateral motor pathway with congenital brain disorder: a case report. Arch Phys Med Rehabil (2001) 1.39
Metabolic detriment in donor heart valves induced by ischemia and cryopreservation. Ann Thorac Surg (1998) 1.38
The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med (1996) 1.38
A unique 33-kD cysteine proteinase accumulates in response to larval feeding in maize genotypes resistant to fall armyworm and other Lepidoptera. Plant Cell (2000) 1.33
Regulation of HIV expression: mechanisms of action of Tat and Rev. AIDS (1991) 1.31
Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta. J Biol Chem (1983) 1.31
KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol (1999) 1.30
HHV8 and skin cancers in immunosuppressed patients. Lancet (1996) 1.29
Manganese exposure and cognitive deficits: a growing concern for manganese neurotoxicity. Neurotoxicology (2012) 1.27
Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus. Annu Rev Med (2001) 1.27
Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am J Epidemiol (1998) 1.26
Switching to gatekeeping: changes in expenditures and utilization for children. Pediatrics (2001) 1.26
Clear cell change in primary thyroid tumors. A study of 38 cases. Am J Surg Pathol (1985) 1.26
Mechanisms of filtration failure during postischemic injury of the human kidney. A study of the reperfused renal allograft. J Clin Invest (1995) 1.24
Distribution of medical insurance in China. Soc Sci Med (1995) 1.23
Pancreas transplantation. An immunohistologic and histopathologic examination of 100 grafts. Am J Pathol (1987) 1.21
Endometrial cancer in women 40 years old or younger. Gynecol Oncol (2001) 1.20
Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. Trends Genet (1998) 1.20
Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale. Stroke (1999) 1.19